Lifestyle and Empowerment Techniques in Survivorship of Gynaecologic Oncology (LETSGO study): a study protocol for a multicentre longitudinal interventional study using mobile health technology and biobanking

Ingvild Vistad, Mette Skorstad, Ingrid Demmelmaier, Milada Cvancarova Småstuen, Kristina Lindemann, Torbjørn Wisløff, Lonneke V van de Poll-Franse, Sveinung Berntsen, Ingvild Vistad, Mette Skorstad, Ingrid Demmelmaier, Milada Cvancarova Småstuen, Kristina Lindemann, Torbjørn Wisløff, Lonneke V van de Poll-Franse, Sveinung Berntsen

Abstract

Introduction: The number of gynaecological cancer survivors is increasing and there is a need for a more sustainable model of follow-up care. Today's follow-up model is time-consuming and patients have reported unmet needs regarding information about their cancer and strategies for managing the consequences of treatment. The main aim of this study is to assess health-related empowerment-in terms of patient education, psychosocial support, and promotion of physical activity-in a new follow-up model by comparing it to standard follow-up in a quasi-randomised study involving intervention hospitals and control hospitals.

Methods and analysis: At the intervention hospitals, patients will be stratified by risk of recurrence and late effects to either 1 or 3 years' follow-up. Nurses will replace doctors in half of the follow-up visits and focus in particular on patient education, self-management and physical activity. They will provide patients with information and guide them in goal setting and action planning. These measures will be reinforced by a smartphone application for monitoring symptoms and promoting physical activity. At the control hospitals, patients will be included in the standard follow-up programme. All patients will be asked to complete questionnaires at baseline and after 3, 6, 12, 24 and 36 months. Blood samples will be collected for biobanking at 3, 12 and 36 months. The primary outcome is health-related empowerment. Secondary outcomes include health-related quality of life, adherence to physical activity recommendations, time to recurrence, healthcare costs and changes in biomarkers. Changes in these outcomes will be analysed using generalised linear mixed models for repeated measures. Type of hospital (intervention or control), time (measurement point), and possible confounders will be included as fixed factors.

Ethics and dissemination: The study is approved by the Regional Committee for Medical Research Ethics (2019/11093). Dissemination of findings will occur at the local, national and international levels.

Trial registration number: NCT04122235.

Keywords: change management; gynaecological oncology; health economics; information technology; protocols & guidelines; quality in health care.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
The LETSGO-app (Anette Gjoerv). LETSGO, Lifestyle and Self-Management Techniques in Survivorship of Gynaecologic Oncology.

References

    1. Ferlay J, Colombet M, Soerjomataram I, et al. . Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019;144:1941–53. 10.1002/ijc.31937
    1. Jacobs LA, Shulman LN. Follow-up care of cancer survivors: challenges and solutions. Lancet Oncol 2017;18:e19–29. 10.1016/S1470-2045(16)30386-2
    1. Leeson SC, Beaver K, Ezendam NPM, et al. . The future for follow-up of gynaecological cancer in Europe. summary of available data and overview of ongoing trials. Eur J Obstet Gynecol Reprod Biol 2017;210:376–80. 10.1016/j.ejogrb.2017.01.025
    1. Coleman K, Austin BT, Brach C, et al. . Evidence on the chronic care model in the new millennium. Health Aff 2009;28:75–85. 10.1377/hlthaff.28.1.75
    1. Alfano CM, Mayer DK, Bhatia S, et al. . Implementing personalized pathways for cancer follow-up care in the United States: proceedings from an American cancer Society-American Society of clinical oncology Summit. CA Cancer J Clin 2019;69:234–47. 10.3322/caac.21558
    1. Beaver K, Williamson S, Sutton C, et al. . Comparing hospital and telephone follow-up for patients treated for stage-I endometrial cancer (ENDCAT trial): a randomised, multicentre, non-inferiority trial. BJOG 2017;124:150–60. 10.1111/1471-0528.14000
    1. Jeppesen MM, Jensen PT, Hansen DG, et al. . Patient-initiated follow up affects fear of recurrence and healthcare use: a randomised trial in early-stage endometrial cancer. BJOG: Int J Obstet Gy 2018;125:1705–14. 10.1111/1471-0528.15396
    1. Lanceley A, Berzuini C, Burnell M, et al. . Ovarian cancer follow-up: a preliminary comparison of 2 approaches. Int J Gynecol Cancer 2017;27:59–68. 10.1097/IGC.0000000000000877
    1. McCabe MS, Partridge AH, Grunfeld E, et al. . Risk-based health care, the cancer survivor, the oncologist, and the primary care physician. Semin Oncol 2013;40:804–12. 10.1053/j.seminoncol.2013.09.004
    1. Vistad I, Cvancarova M, Fosså SD, et al. . Postradiotherapy morbidity in long-term survivors after locally advanced cervical cancer: how well do physicians' assessments agree with those of their patients? Int J Radiat Oncol Biol Phys 2008;71:1335–42. 10.1016/j.ijrobp.2007.12.030
    1. Vistad I, Cvancarova M, Kristensen GB, et al. . A study of chronic pelvic pain after radiotherapy in survivors of locally advanced cervical cancer. J Cancer Surviv 2011;5:208–16. 10.1007/s11764-011-0172-z
    1. Vistad I, Kristensen GB, Fosså SD, et al. . Intestinal malabsorption in long-term survivors of cervical cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys 2009;73:1141–7. 10.1016/j.ijrobp.2008.05.064
    1. Vistad I, Fosså SD, Kristensen GB, et al. . Chronic fatigue and its correlates in long-term survivors of cervical cancer treated with radiotherapy. BJOG 2007;114:1150–8. 10.1111/j.1471-0528.2007.01445.x
    1. Steen R, Dahl AA, Hess SL, et al. . A study of chronic fatigue in Norwegian cervical cancer survivors. Gynecol Oncol 2017;146:630–5. 10.1016/j.ygyno.2017.05.028
    1. Liavaag AH, Dørum A, Fosså SD, et al. . Controlled study of fatigue, quality of life, and somatic and mental morbidity in epithelial ovarian cancer survivors: how lucky are the lucky ones? J Clin Oncol 2007;25:2049–56. 10.1200/JCO.2006.09.1769
    1. Cianci S, Rosati A, Capozzi VA, et al. . Quality of life and sexual functioning of patient affected by endometrial cancer. Minerva Med 2021;112:81–95. 10.23736/S0026-4806.20.07081-0
    1. Cianci S, Tarascio M, Rosati A, et al. . Sexual function and quality of life of patients affected by ovarian cancer. Minerva Med 2019;110:320–9. 10.23736/S0026-4806.19.06080-4
    1. Vistad I, Bjørge L, Solheim O, et al. . A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway. Acta Obstet Gynecol Scand 2017;96:1162–9. 10.1111/aogs.13199
    1. Rosenberg CA, Flanagan C, Brockstein B, et al. . Promotion of self-management for post treatment cancer survivors: evaluation of a risk-adapted visit. J Cancer Surviv 2016;10:206–19. 10.1007/s11764-015-0467-6
    1. Maunsell E, Lauzier S, Brunet J, et al. . Health-related empowerment in cancer: validity of scales from the health education impact questionnaire. Cancer 2014;120:3228–36. 10.1002/cncr.28847
    1. Davy C, Bleasel J, Liu H, et al. . Effectiveness of chronic care models: opportunities for improving healthcare practice and health outcomes: a systematic review. BMC Health Serv Res 2015;15:194. 10.1186/s12913-015-0854-8
    1. Thomaier L, Jewett P, Brown K, et al. . The associations between physical activity, neuropathy symptoms and health-related quality of life among gynecologic cancer survivors. Gynecol Oncol 2020;158:361–5. 10.1016/j.ygyno.2020.05.026
    1. Friedenreich CM, Cook LS, Wang Q, et al. . Prospective cohort study of pre- and postdiagnosis physical activity and endometrial cancer survival. J Clin Oncol 2020;38:Jco2001336. 10.1200/JCO.20.01336
    1. Rock CL, Thomson C, Gansler T, et al. . American cancer Society guideline for diet and physical activity for cancer prevention. CA Cancer J Clin 2020;70:245–71. 10.3322/caac.21591
    1. von Gruenigen VE, Waggoner SE, Frasure HE, et al. . Lifestyle challenges in endometrial cancer survivorship. Obstet Gynecol 2011;117:93–100. 10.1097/AOG.0b013e31820205b3
    1. Samdal GB, Eide GE, Barth T, et al. . Effective behaviour change techniques for physical activity and healthy eating in overweight and obese adults; systematic review and meta-regression analyses. Int J Behav Nutr Phys Act 2017;14:42. 10.1186/s12966-017-0494-y
    1. Schinköthe T. Individualized eHealth support for oncological therapy management. Breast Care 2019;14:130–4. 10.1159/000500900
    1. Purswani JM, Dicker AP, Champ CE, et al. . Big data from small devices: the future of Smartphones in oncology. Semin Radiat Oncol 2019;29:338–47. 10.1016/j.semradonc.2019.05.008
    1. Furness K, Sarkies MN, Huggins CE, et al. . Impact of the method of delivering electronic health behavior change interventions in survivors of cancer on engagement, health behaviors, and health outcomes: systematic review and meta-analysis. J Med Internet Res 2020;22:e16112. 10.2196/16112
    1. Triberti S, Savioni L, Sebri V, et al. . eHealth for improving quality of life in breast cancer patients: a systematic review. Cancer Treat Rev 2019;74:1–14. 10.1016/j.ctrv.2019.01.003
    1. Denis F, Lethrosne C, Pourel N, et al. . Randomized trial comparing a Web-Mediated follow-up with routine surveillance in lung cancer patients. J Natl Cancer Inst 2017;109:djx029. 10.1093/jnci/djx029
    1. Lyu K-X, Zhao J, Wang B, et al. . Smartphone application WeChat for clinical follow-up of discharged patients with head and neck tumors: a randomized controlled trial. Chin Med J 2016;129:2816–23. 10.4103/0366-6999.194635
    1. Ormel HL, van der Schoot GGF, Westerink N-DL, et al. . Self-monitoring physical activity with a smartphone application in cancer patients: a randomized feasibility study (SMART-trial). Support Care Cancer 2018;26:3915–23. 10.1007/s00520-018-4263-5
    1. Schrepf A, Clevenger L, Christensen D, et al. . Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability. Brain Behav Immun 2013;30 Suppl:S126–34. 10.1016/j.bbi.2012.07.022
    1. Duffy SA, Taylor JMG, Terrell JE, et al. . Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer 2008;113:750–7. 10.1002/cncr.23615
    1. Trompet S, de Craen AJM, Mooijaart S, et al. . High innate production capacity of proinflammatory cytokines increases risk for death from cancer: results of the PROSPER study. Clin Cancer Res 2009;15:7744–8. 10.1158/1078-0432.CCR-09-2152
    1. Kitson SJ, Lindsay J, Sivalingam VN, et al. . The unrecognized burden of cardiovascular risk factors in women newly diagnosed with endometrial cancer: a prospective case control study. Gynecol Oncol 2018;148:154–60. 10.1016/j.ygyno.2017.11.019
    1. Chan A-W, Tetzlaff JM, Altman DG, et al. . Spirit 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013;158:200–7. 10.7326/0003-4819-158-3-201302050-00583
    1. Bourke L, Homer KE, Thaha MA, et al. . Interventions for promoting habitual exercise in people living with and beyond cancer. Cochrane Database Syst Rev 2013;92:CD010192. 10.1002/14651858.CD010192.pub2
    1. Turner RR, Steed L, Quirk H, et al. . Interventions for promoting habitual exercise in people living with and beyond cancer. Cochrane Database Syst Rev 2018;9:Cd010192. 10.1002/14651858.CD010192.pub3
    1. Finne E, Glausch M, Exner A-K, et al. . Behavior change techniques for increasing physical activity in cancer survivors: a systematic review and meta-analysis of randomized controlled trials. Cancer Manag Res 2018;10:5125–43. 10.2147/CMAR.S170064
    1. Vistad I, Moy BW, Salvesen HB, et al. . Follow-up routines in gynecological cancer - time for a change? Acta Obstet Gynecol Scand 2011;90:707–18. 10.1111/j.1600-0412.2011.01123.x
    1. Miller WR, Rollnick S. Meeting in the middle: motivational interviewing and self-determination theory. Int J Behav Nutr Phys Act 2012;9:25. 10.1186/1479-5868-9-25
    1. Kulis D, Bottomley A, Whittaker C, et al. . The use of the EORTC item library to supplement EORTC quality of life instruments. Value in Health 2017;20:A775. 10.1016/j.jval.2017.08.2236
    1. Osborne RH, Elsworth GR, Whitfield K. The health education impact questionnaire (heiQ): an outcomes and evaluation measure for patient education and self-management interventions for people with chronic conditions. Patient Educ Couns 2007;66:192–201. 10.1016/j.pec.2006.12.002
    1. Wahl AK, Osborne RH, Langeland E, et al. . Making robust decisions about the impact of health education programs: psychometric evaluation of the health education impact questionnaire (heiQ) in diverse patient groups in Norway. Patient Educ Couns 2016;99:1733–8. 10.1016/j.pec.2016.05.001
    1. Aaronson NK, Ahmedzai S, Bergman B, et al. . The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–76. 10.1093/jnci/85.5.365
    1. Nord E. EuroQol: health-related quality of life measurement. Valuations of health states by the general public in Norway. Health Policy 1991;18:25–36. 10.1016/0168-8510(91)90141-J
    1. Stukan M, Zalewski K, Mardas M, et al. . Independent psychometric validation of European organization for research and treatment of cancer quality of life Questionnaire-Endometrial cancer module (EORTC QLQ-EN24). Eur J Cancer Care 2018;27:ecc.12639. 10.1111/ecc.12639
    1. Greimel E, Bottomley A, Cull A, et al. . An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. Eur J Cancer 2003;39:1402–8. 10.1016/S0959-8049(03)00307-1
    1. Greimel ER, Kuljanic Vlasic K, Waldenstrom A-C, et al. . The European organization for research and treatment of cancer (EORTC) quality-of-life questionnaire cervical cancer module: EORTC QLQ-CX24. Cancer 2006;107:1812–22. 10.1002/cncr.22217
    1. Knobel H, Loge JH, Brenne E, et al. . The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors. Palliat Med 2003;17:664–72. 10.1191/0269216303pm841oa
    1. Ekelund U, Sepp H, Brage S, et al. . Criterion-related validity of the last 7-day, short form of the International physical activity questionnaire in Swedish adults. Public Health Nutr 2006;9:258–65. 10.1079/PHN2005840
    1. Nigg C, Riebe D. The transtheoretical model: research review of exercise behavior in older adults. In: Burbank P, Riebe D, eds. Promoting exercise and behavior change in older adults: interventions with the transtheoretical model. New York: Springer, 2002: 147–80.
    1. Prochaska JO, DiClemente C, Norcross JC. In search of how people change. American Psychologist 1992;47:1002–14.
    1. Zebrack BJ, Ganz PA, Bernaards CA, et al. . Assessing the impact of cancer: development of a new instrument for long-term survivors. Psychooncology 2006;15:407–21. 10.1002/pon.963
    1. Hofsø K, Miaskowski C, Bjordal K, et al. . Previous chemotherapy influences the symptom experience and quality of life of women with breast cancer prior to radiation therapy. Cancer Nurs 2012;35:167–77. 10.1097/NCC.0b013e31821f5eb5
    1. Oksholm T, Rustoen T, Cooper B, et al. . Trajectories of symptom occurrence and severity from before through five months after lung cancer surgery. J Pain Symptom Manage 2015;49:995–1015. 10.1016/j.jpainsymman.2014.11.297
    1. Holmen H, Torbjørnsen A, Wahl AK, et al. . A mobile health intervention for self-management and lifestyle change for persons with type 2 diabetes, part 2: one-year results from the Norwegian randomized controlled trial RENEWING health. JMIR Mhealth Uhealth 2014;2:e57. 10.2196/mhealth.3882
    1. Elsworth GR, Osborne RH. Percentile ranks and benchmark estimates of change for the health education impact questionnaire: normative data from an Australian sample. SAGE Open Med 2017;5:205031211769571. 10.1177/2050312117695716
    1. Ramsey SD, Willke RJ, Glick H, et al. . Cost-Effectiveness analysis alongside clinical trials II-An ISPOR good research practices Task force report. Value Health 2015;18:161–72. 10.1016/j.jval.2015.02.001

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren